Every Form 4 that Cimpress Plc (CMPR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CMPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CMPR filings page.
CIMPRESS plc (CMPR) reported that CEO and Chairman Robert S. Keane exercised performance share units into ordinary shares on August 15, 2026. A total of 44,614 ordinary shares were acquired at a conversion price of $0.00 per share upon vesting of multiple performance share unit awards. In a related transaction, 17,624 ordinary shares at $94.46 per share were delivered or withheld for payment of exercise price or tax liability. The filing also lists indirect holdings of ordinary shares through several entities, including RHS Delaware Holdings LLC, Eastern Irrevocable, LLC, Western Irrevocable, LLC, and others.
CIMPRESS plc (CMPR) reported that EVP and Chief Financial Officer Sean Edward Quinn exercised equity awards on August 15, 2026. Restricted share units and performance share units covering 23,319 ordinary shares were converted into ordinary shares at a $0.00 exercise price. In a related transaction, 11,277 ordinary shares were delivered or withheld at $94.46 per share for payment of exercise price or tax liability.
CIMPRESS plc (CMPR) reported insider equity transactions by EVP & Chief Technology Officer Maarten Wensveen. On 2026-08-15, he exercised derivative awards covering 18,543 ordinary shares in total, consisting of restricted share units and performance share units that vested pursuant to prior awards. In connection with these exercises, 8,968 ordinary shares were delivered or withheld at $94.46 per share for payment of exercise price or tax liability. Resulting ordinary-share holdings after these transactions are not stated.
CIMPRESS plc (CMPR) reported insider equity award activity by Florian Baumgartner, EVP and CEO of Vista. On 2026-08-15 he exercised or converted restricted share units and performance share units covering 18,354 Ordinary Shares at a conversion price of $0.00 per share, receiving the underlying shares. On the same date, 8,716 Ordinary Shares at $94.46 per share were delivered or withheld to satisfy payment of exercise price or tax liability, resulting in both acquisitions and dispositions but no net open-market buying or selling.
Cimpress plc director and CEO Robert S. Keane reported open‑market sales of a total of 6,500 Ordinary Shares on August 11, 2026, at per‑share prices including $95.33, $96.50 and $97.06. Footnotes state that the first two trades reflect weighted‑average sale prices over price ranges of $95.00–$95.99 and $96.00–$96.91, respectively. Keane continues to report substantial indirect holdings of Cimpress Ordinary Shares through entities such as RHS Delaware Holdings LLC (28,375 shares, owned by Eastern Irrevocable, LLC and Western Irrevocable, LLC), Second Delaware 2003, LLC (780,000 shares) and Third Delaware 2011, LLC (986,785 shares).
Baumgartner Florian reported acquisition or exercise transactions in this Form 4 filing.
CIMPRESS plc reported that executive Florian Baumgartner, EVP and CEO of Vista, received a grant of 47,239 Performance Share Units (PSUs). These PSUs were originally granted on August 15, 2025 and are tied to adjusted EBITDA and variable gross profit for Vista for the fiscal year ended June 30, 2026. On August 7, 2026, the compensation committee determined that 47,239 ordinary shares are issuable under this award, with each PSU representing one ordinary share. The PSUs vest over four years: 25% on August 15, 2026 and 6.25% of the total quarterly thereafter.
Cimpress plc executive Maarten Wensveen reported an equity award tied to prior performance. He acquired 46,731 Performance Share Units (PSUs), each representing the commitment to issue one ordinary share, after the Compensation Committee on August 7, 2026 determined the number of shares earned based on adjusted EBITDA and variable gross profit performance for the fiscal year ended June 30, 2026.
The PSUs were originally granted on August 15, 2025 and vest over four years: 25% of the determined shares vest on August 15, 2026, and 6.25% of the shares vest quarterly thereafter. Following this determination, Wensveen directly holds 46,731 PSUs linked to Cimpress ordinary shares.
Cimpress plc reported that EVP and CFO Sean Edward Quinn acquired 59,194 Performance Share Units (PSUs). These PSUs relate to an award granted on August 15, 2025, with performance conditions based on adjusted EBITDA and variable gross profit for the fiscal year ended June 30, 2026. On August 7, 2026, the Compensation Committee determined the number of shares issuable, with each PSU representing one ordinary share. The PSUs vest over four years: 25% on August 15, 2026 and 6.25% of the determined shares vesting quarterly thereafter, and are scheduled to expire on August 15, 2029.
Keane Robert S reported acquisition or exercise transactions in this Form 4 filing.
Cimpress plc reported that CEO and Chairman Robert S. Keane received two performance share unit (PSU) awards tied to fiscal year ended June 30, 2026 performance. On August 7, 2026, the Compensation Committee determined 121,503 PSUs for his CEO role and 3,115 PSUs for his director role, each PSU representing one ordinary share. These PSUs are exercisable beginning August 15, 2026 and expire on August 15, 2029, with multi-year vesting schedules.
Florian Baumgartner, EVP and CEO of Vista at Cimpress, reported equity compensation activity dated July 15, 2026. He exercised 1,026 restricted share units into the same number of ordinary shares at a conversion price of $0, while 488 ordinary shares were withheld at $98.52 per share to satisfy tax or exercise obligations. The RSU award vests over four years, with 25% vesting on the initial exercisable date and 6.25% vesting quarterly thereafter, and he continues to hold both ordinary shares and unvested RSUs.
Cimpress plc EVP and CFO Sean Edward Quinn reported multiple transactions in the company’s ordinary shares. On May 27–28, 2026, he exercised options to acquire 5,009 shares at $46.20 per share, then sold a total of 27,989 shares in open‑market trades at weighted‑average prices around $103.51–$105.48, as detailed by price ranges in the footnotes. After these transactions, Quinn directly holds 28,937 ordinary shares. No remaining derivative positions are shown in this filing for the exercised option grant.
Cimpress plc executive Florian Baumgartner, EVP and CEO of Vista, reported routine equity award activity in the form of vesting and exercises of share units into ordinary shares. On May 15, 2026, he exercised awards covering 6,544 ordinary shares through the conversion of restricted share units and performance share units that automatically vested under their existing schedules.
To satisfy tax obligations linked to these vestings, 3,108 ordinary shares were disposed of at $93.25 per share via tax withholding, a non‑market transaction rather than an open‑market sale. Following these transactions, Baumgartner continues to hold a substantial direct position in Cimpress ordinary shares, and no open‑market purchases or sales were reported in this filing.
CIMPRESS plc EVP and Chief Financial Officer Sean Edward Quinn reported equity award activity on May 15, 2026. He exercised 2,300 restricted share units and performance share units covering 4,571 and 1,650 ordinary shares, for 8,521 shares in total, at an exercise price of $0.00 per share. To satisfy tax obligations, 3,463 ordinary shares were delivered back to the company at $93.25 per share in a tax-withholding disposition rather than an open-market sale. After these transactions, he directly holds 51,917 ordinary shares and 37,707 performance share units.
Cimpress plc EVP and Chief Technology Officer Wensveen Maarten reported routine equity compensation activity in ordinary shares. On May 15, 2026, he exercised previously granted restricted and performance share units into 6,860 ordinary shares at a conversion price of $0.00 per share. To cover tax obligations, 3,282 shares were disposed of at $93.25 per share through a tax-withholding transaction, rather than an open-market sale. Following the reported transactions, he directly holds 23,252 ordinary shares of Cimpress.
Cimpress plc director Ting Wayne Hsing-Yuan reported routine equity compensation activity involving restricted share units (RSUs). On May 15, 2026, 582 ordinary shares were acquired at a price of $0.00 per share through the automatic vesting and exercise of RSUs, with each RSU converting into one ordinary share. On the same date, 280 ordinary shares were disposed of at $93.25 per share as a tax-withholding disposition to cover tax obligations. Following these transactions, the filing shows direct ownership of 302 ordinary shares. Footnotes explain that the RSU award vests over a four-year period, with 25% vesting initially and 25% vesting yearly thereafter.
Cimpress plc director and CEO Robert S. Keane reported routine equity compensation activity involving performance share units (PSUs) and ordinary shares. On May 15, 2026, PSUs automatically vested based on performance conditions, resulting in the issuance of 13,112 ordinary shares at a conversion price of $0.00 per share through multiple PSU awards.
To cover tax obligations, 4,522 ordinary shares were disposed of at $93.25 per share as a tax-withholding transaction, a non-market sale to the issuer, leaving 82,677 ordinary shares held directly. Keane also reports substantial indirect ownership of Cimpress ordinary shares through several Delaware LLCs and a Delaware investment trust, including 986,785 shares held by Third Delaware 2011, LLC and 780,000 shares held by Second Delaware 2003, LLC.
The filing notes that each PSU represents a commitment to issue one ordinary share upon determination of performance outcomes, with awards vesting over four years, including an initial 25% vesting and subsequent quarterly vesting at 6.25% of the performance-determined amount.
Cimpress plc executive Maarten Wensveen, EVP & Chief Technology Officer, reported an exercise-and-sell transaction in the company’s ordinary shares. On May 5, 2026, he exercised options to acquire 10,000 ordinary shares at an exercise price of $46.20 per share.
That same day, he completed multiple open‑market sales totaling 19,251 ordinary shares at weighted‑average prices with per‑share sale prices ranging from $90.59 to $94.79, according to footnotes. After these transactions, he directly owns 38,546 ordinary shares and holds 50,013 options to purchase additional ordinary shares.
Cimpress plc executive Florian Baumgartner exercised restricted share units that converted into ordinary shares as part of his equity compensation. On this date, 9,288 RSUs were exercised into ordinary shares, with 4,411 shares withheld at a price of $80.49 per share to cover tax obligations. Following these transactions, Baumgartner directly held 68,720 Cimpress ordinary shares. The filing reflects routine vesting and tax withholding activity rather than open-market buying or selling.
Cimpress plc CEO and Chairman Robert S. Keane reported equity award activity involving performance share units (PSUs) and ordinary shares. On February 15, 2026, PSUs were exercised or converted into ordinary shares in several blocks, including 9,578, 146, and 3,388 PSUs at a price of $0.00 per unit, reflecting automatic vesting based on performance conditions.
Corresponding ordinary share entries show Keane acquiring the same amounts of ordinary shares through derivative exercise. In a separate transaction coded F, 4,117 ordinary shares at $74.27 per share were disposed of to satisfy tax obligations related to these awards. After these transactions, Keane directly owned 74,087 ordinary shares. The filing also notes additional ordinary shares held indirectly through entities such as RHS Delaware Holdings LLC and several related LLCs and trusts.
Cimpress plc EVP & Chief Technology Officer Maarten Wensveen reported equity award vesting and related share movements. On February 15, 2026, he acquired a total of 6,860 ordinary shares through automatic vesting and conversion of restricted share units and performance share units at no exercise price.
Following these transactions, including a 2,063-share tax-withholding disposition at $74.27 per share, Wensveen directly held 28,925 Cimpress ordinary shares. The footnotes explain that each RSU and PSU represented Cimpress’ commitment to issue one ordinary share, vesting over a four-year schedule.
Cimpress plc EVP and CFO Sean Edward Quinn reported equity award activity on February 15, 2026. He acquired 2,300 ordinary shares from vested restricted share units and 6,222 ordinary shares from vested performance share units through derivative exercises at $0.00 per share. To satisfy tax obligations, 2,546 ordinary shares were disposed of at $74.27 per share. After these transactions, he directly owned 46,859 ordinary shares.
Cimpress plc executive Florian Baumgartner reported equity award vesting and related share movements. On February 15, 2026, restricted share units and performance share units automatically vested, representing Cimpress’ commitment to issue one ordinary share for each vested unit.
These awards converted into ordinary shares at no exercise price, increasing his direct holdings, including 1,691 shares from restricted share units and additional shares from performance share units based on performance conditions. On the same date, 3,106 ordinary shares at $74.27 per share were disposed of to satisfy tax withholding obligations, a non‑open‑market, tax-related transaction, leaving 63,843 ordinary shares held directly.
Cimpress plc executive Florian Baumgartner reported equity transactions involving company stock. On 01/15/2026, 1,026 restricted share units automatically vested, with each RSU converting into one ordinary share at a price of $0, reflecting Cimpress’ prior commitment to issue these shares.
On the same date, 488 ordinary shares were disposed of at $79.73 per share. After these transactions, Baumgartner directly held 60,405 ordinary shares and 4,102 restricted share units. The RSU award vests over four years, with 25% of the original grant vesting on the initial vesting date and 6.25% vesting quarterly thereafter.
Cimpress plc director and 10% owner Scott J. Vassalluzzo reported multiple equity transactions in Cimpress ordinary shares on 11/15/2025. Several blocks of restricted share units (RSUs) vested, delivering 351, 1,128, 494, and 638 ordinary shares at an exercise price of $0 per share as the company fulfilled prior RSU awards. To cover obligations associated with these awards, 1,256 shares were disposed of at $66.59 per share.
Following these transactions, Mr. Vassalluzzo held 72,734 ordinary shares directly, with additional indirect beneficial ownership reported through various Prescott-related investment entities and family accounts, including 2,636,492 shares held by Prescott Associates L.P. Each RSU grant vests over four years, with 25% vesting on the initial date shown and 25% vesting on each yearly anniversary.
Cimpress plc director Dessislava Temperley reported restricted share unit (RSU) vesting and related share transactions. On 11/15/2025, RSUs vested and were exercised into 351, 1,128, 494, and 638 ordinary shares at an exercise price of $0 per share, increasing her direct holdings. On the same date, she disposed of 1,256 ordinary shares at $66.59 per share. Following these transactions, she directly beneficially owned 4,285 Cimpress ordinary shares, and continues to hold additional unvested or unexercised RSUs as shown in the derivative securities table.
Cimpress plc (CMPR) director Sophie Gasperment reported equity transactions on 11/15/2025 involving the vesting of restricted share units (RSUs) and a share sale. Several RSU awards vested and converted into ordinary shares, including 351, 1,128, 494 and 638 ordinary shares, each at an exercise price of $0 as these are RSUs rather than options. Following these transactions, she continued to hold ordinary shares directly.
The filing also shows a disposition of 1,256 ordinary shares coded “F” at a price of $66.59, typically indicating shares withheld or sold to cover taxes associated with the vesting. The RSU awards referenced in Table II vest over four years, with 25% of the original RSU grant vesting on the initial vesting date and another 25% vesting each year thereafter.
Cimpress plc CEO, Chairman and Director Robert S. Keane reported equity award activity involving performance share units (PSUs). On 11/15/2025, three PSU awards vested and were settled in ordinary shares, delivering 9,579, 146 and 3,388 ordinary shares at an exercise price of $0 per share. To cover related obligations, 5,404 ordinary shares were disposed of at $66.59 per share. Following these transactions, he directly owned 65,092 ordinary shares. He also reported substantial indirect holdings through several entities, including 220,503 shares via the Keane Family Foundation and 986,785 shares via Third Delaware 2011, LLC.
Cimpress plc executive vice president and chief technology officer Maarten Wensveen reported equity transactions in the company’s ordinary shares on 11/15/2025. Several awards of restricted share units and performance share units were exercised at an exercise price of $0, resulting in acquisitions of 1,860, 3,697, and 1,303 ordinary shares as those units vested. On the same date, 3,319 ordinary shares were disposed of at a price of $66.59 per share. Following these transactions, Wensveen directly beneficially owned 24,128 Cimpress ordinary shares.
Cimpress plc (CMPR) executive Sean E. Quinn reported equity award activity on a Form 4. On 11/15/2025, Quinn, the company’s EVP and Chief Financial Officer, exercised vested restricted share units (RSUs) and performance share units (PSUs), each representing the right to receive one ordinary share upon vesting.
The filing shows multiple “M” transactions in which RSUs and PSUs converted into ordinary shares at an exercise price of $0, and one “F” transaction in which 4,121 ordinary shares were disposed of at $66.59 per share. After these transactions, Quinn directly owned 40,883 ordinary shares and continued to hold additional RSUs and PSUs that vest over a four-year period, with 25% vesting on the listed exercisable dates and 6.25% vesting quarterly thereafter.
Cimpress plc executive reports share vesting and sale activity. On 11/15/2025, EVP and CEO, Vista, Florian Baumgartner acquired 1,691 ordinary shares from vested restricted share units and 3,550 and 1,303 ordinary shares from vested performance share units, all at an exercise price of $0. On the same date, 3,108 ordinary shares were disposed of at $66.59 per share. Following these transactions, he directly beneficially owned 59,867 Cimpress ordinary shares, along with outstanding restricted share units and performance share units that continue to vest over a four-year schedule.
Cimpress plc (CMPR) reported an insider buy by its EVP, Chief Financial Officer, Sean E. Quinn. On 11/06/2025, Quinn executed multiple open‑market purchases totaling 4,000 ordinary shares at prices ranging from $61.83 to $63.00.
Following these transactions, Quinn beneficially owned 36,484 ordinary shares, held directly, as reflected after each reported trade.
Cimpress plc (CMPR) — Form 4 insider sale: EVP & Chief Technology Officer Maarten Wensveen sold Cimpress ordinary shares on 11/03/2025. Reported sales were 21,010 shares at a weighted-average price of $68.24, 1,294 shares at $69.30, and 526 shares at $70.74. The prices reflect weighted averages within disclosed ranges. Following these transactions, he beneficially owned 20,587 shares, held directly.
The filing notes price ranges for each trade: $67.98–$68.97, $68.99–$69.95, and $70.02–$70.93, and states that detailed price-by-size information will be provided upon request.
Cimpress (CMPR) executive Florian Baumgartner reported equity transactions on 10/15/2025. 1,025 ordinary shares were acquired upon RSU vesting (code M) at $0, and 487 shares were disposed (code F) at $64.18 for tax withholding. After these transactions, he holds 56,431 ordinary shares directly and 5,128 RSUs.
The RSUs vest over four years: 25% on the initial vesting date and 6.25% quarterly thereafter.
Cimpress plc director Dessislava Temperley reported insider transactions on 09/15/2025. 435 restricted share units (RSUs) vested and converted into 435 ordinary shares at no cash cost, increasing her holdings to 3,139 ordinary shares. On the same date she disposed of 209 ordinary shares at an average price of $57.10 per share, leaving her with 2,930 shares after the sale. The RSUs referenced were part of a grant that began vesting on 09/15/2022 and vest over four years (25% at the initial vesting date and 25% annually thereafter). The Form 4 was signed by an attorney-in-fact on 09/16/2025.